Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      2000 medicines to become up to 90 percent cheaper: Nadda

      2000 medicines to become up to 90 percent cheaper: Nadda

      savita thakur thakur7 Nov 2016 1:24 PM IST
      Union Health Minister JP Nadda has said nearly 2,000 medicines will be made available at rates up to 90 per cent less than the maximum retail price...
      Drugmakers under fire for possible US price fixing

      Drugmakers under fire for possible US price fixing

      savita thakur thakur7 Nov 2016 1:15 PM IST
      Two prominent U.S. lawmakers called on federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co, Merck & Co Inc and Novo Nordisk...
      Pharma cos see huge sell off: Sun Pharma, Dr Reddys hit hard

      Pharma cos see huge sell off: Sun Pharma, Dr Reddys hit hard

      savita thakur thakur7 Nov 2016 1:12 PM IST
      Pharma stocks came under massive selling pressure, falling by up to 7.4 per cent amid reports that US prosecutors could file charges by year-end in an...
      U.S. FDA panel narrowly backs Cempra antibiotic solithromycin

      U.S. FDA panel narrowly backs Cempra antibiotic solithromycin

      savita thakur thakur7 Nov 2016 1:10 PM IST
      The effectiveness of Cempra Inc's antibiotic to treat community-acquired pneumonia outweighs the risk of liver injury, an advisory panel to the U.S....
      Health insurer Cigna wont expand Obamacare to more states

      Health insurer Cigna won't expand Obamacare to more states

      savita thakur thakur6 Nov 2016 9:09 AM IST
      Health insurer Cigna Corp said it would not expand its individual Obamacare plans into more states next year, joining an industry pullback from the...
      Strides, Mylan agree to settle claims on Agila sale

      Strides, Mylan agree to settle claims on Agila sale

      savita thakur thakur5 Nov 2016 11:06 AM IST
      New Delhi : Pharma major Strides Shasun and the US-based Mylan have agreed to settle regulatory and general claims on Agila transaction.Strides had...
      Adverse events in trial dent hopes for Roche hemophilia drug

      Adverse events in trial dent hopes for Roche hemophilia drug

      savita thakur thakur5 Nov 2016 11:06 AM IST
      Four patients have suffered serious adverse events in a clinical trial of an experimental hemophilia medicine from Roche, the Swiss group said,...
      Vyome Biosciences Administers First In-human Dose in US Phase 1 Clinical Study in Patients with Facial Acne Vulgaris

      Vyome Biosciences Administers First In-human Dose in US Phase 1 Clinical Study in Patients with Facial Acne Vulgaris

      savita thakur thakur5 Nov 2016 9:04 AM IST
      New Delhi : Vyome Biosciences, a clinical-stage specialty bio pharmaceutical company developing novel medicines for treating skin diseases caused by...
      Siemens Healthineers introduces robot-supported Artis pheno angiography system

      Siemens Healthineers introduces robot-supported Artis pheno angiography system

      savita thakur thakur4 Nov 2016 1:06 PM IST
      Siemens Healthineers introduces the innovative robot-supported Artis pheno angiography system at this year’s German Congress for Orthopedics and...
      Lupin gets final nod from USFDA for birth control pill

      Lupin gets final nod from USFDA for birth control pill

      savita thakur thakur4 Nov 2016 11:44 AM IST
      New Delhi : Drug firm Lupin BSE -4.32 % has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol...
      EMA accepts marketing application of Biocon, Mylan insulin glargine

      EMA accepts marketing application of Biocon, Mylan insulin glargine

      savita thakur thakur4 Nov 2016 11:40 AM IST
      New Delhi : Biotechnology major Biocon said the European Medicines Agency (EMA) has accepted its request for review of its partner Mylan's marketing...
      Novartis breast cancer drug gets FDA fast track, takes on Pfizer

      Novartis breast cancer drug gets FDA fast track, takes on Pfizer

      savita thakur thakur4 Nov 2016 11:38 AM IST
      Zurich : The U.S. Food and Drug Administration gave fast-track review status to Novartis's medication ribociclib in first-line treatment of...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok